Literature DB >> 17443359

Renal cell carcinoma presenting with paraneoplastic hypercalcemic coma: a case report and review of the literature.

Kara Pepper1, Uraporn Jaowattana, Michael D Starsiak, Raghuueer Halkar, Kelly Hornaman, Wenli Wang, Priya Dayamani, Vin Tangpricha.   

Abstract

We report a case of a 62-year-old woman with renal cell carcinoma (RCC) presenting with a hypercalcemia-induced coma. A laboratory evaluation indicated nonparathyroid-mediated hypercalcemia with an initial serum calcium level of 18.6 mg/dL. Our patient's parathyroid hormone (PTH)-related peptide level was undetectable. Initial imaging was negative, but PET scan identified a mass in the upper pole of the left kidney. Our patient underwent partial nephrectomy, and the mass was identified as RCC on final pathology. After surgery, her hypercalcemia resolved and PTH returned to normal limits. This case report describes a patient with RCC with the unusual presentation of hypercalcemic coma. We review the differential diagnosis of malignant hypercalcemia and the evaluation of hypercalcemia occurring with RCC. This case illustrates the need to carefully review and interpret all available data, especially when conventional testing in the work-up of hypercalcemia is unrevealing.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17443359      PMCID: PMC2219737          DOI: 10.1007/s11606-007-0189-1

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  47 in total

Review 1.  Renal-cell carcinoma.

Authors:  Herbert T Cohen; Francis J McGovern
Journal:  N Engl J Med       Date:  2005-12-08       Impact factor: 91.245

Review 2.  Renal-cell carcinoma.

Authors:  R J Motzer; N H Bander; D M Nanus
Journal:  N Engl J Med       Date:  1996-09-19       Impact factor: 91.245

3.  Indomethacin-responsive hypercalcemia in a patient with renal-cell adenocarcinoma.

Authors:  H D Brereton; P V Halushka; R W Alexander; D M Mason; H R Keiser; V T DeVita
Journal:  N Engl J Med       Date:  1974-06-11       Impact factor: 91.245

4.  Prostaglandin: increased production by renal cell carcinoma.

Authors:  K B Cummings; R P Robertson
Journal:  J Urol       Date:  1977-11       Impact factor: 7.450

5.  Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.

Authors:  Etsuro Onuma; Yumiko Azuma; Hidemi Saito; Toshiaki Tsunenari; Toshihiko Watanabe; Manabu Hirabayashi; Koh Sato; Hisafumi Yamada-Okabe; Etsuro Ogata
Journal:  Clin Cancer Res       Date:  2005-06-01       Impact factor: 12.531

6.  Hypercalcemia in a patient with renal cell carcinoma producing parathyroid hormone-related protein and interleukin-6.

Authors:  M Ueno; S Ban; T Nakanoma; T Tsukamoto; S Nonaka; R Hirata; M Iida; N Deguchi
Journal:  Int J Urol       Date:  2000-06       Impact factor: 3.369

7.  Unknown primary tumors: detection with dual-modality PET/CT--initial experience.

Authors:  Andreas Gutzeit; Gerald Antoch; Hilmar Kühl; Thomas Egelhof; Markus Fischer; Elke Hauth; Susanne Goehde; Andreas Bockisch; Jörg Debatin; Lutz Freudenberg
Journal:  Radiology       Date:  2004-11-24       Impact factor: 11.105

8.  Renal cell carcinoma presenting as acute pancreatitis and GI bleeding.

Authors:  J M Klausner; R R Rozin; S Lelcuck; B Ilie
Journal:  J Surg Oncol       Date:  1983-04       Impact factor: 3.454

9.  Cytoreductive surgery prior to interleukin-2-based therapy in patients with metastatic renal cell carcinoma.

Authors:  M M Walther; R B Alexander; G H Weiss; D Venzon; A Berman; H I Pass; W M Linehan; S A Rosenberg
Journal:  Urology       Date:  1993-09       Impact factor: 2.649

Review 10.  Life-threatening polyneuropathy heralding renal cell carcinoma.

Authors:  Michael J Roy; Eugene F May; Bahman Jabbari
Journal:  Mil Med       Date:  2002-12       Impact factor: 1.437

View more
  6 in total

1.  Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy.

Authors:  Daniel M Moreira; Boris Gershman; Christine M Lohse; Stephen A Boorjian; John C Cheville; Bradley C Leibovich; Robert Houston Thompson
Journal:  World J Urol       Date:  2016-02-25       Impact factor: 4.226

2.  TRPM3 and miR-204 establish a regulatory circuit that controls oncogenic autophagy in clear cell renal cell carcinoma.

Authors:  Daniel P Hall; Nicholas G Cost; Shailaja Hegde; Emily Kellner; Olga Mikhaylova; Yiwen Stratton; Birgit Ehmer; William A Abplanalp; Raghav Pandey; Jacek Biesiada; Christian Harteneck; David R Plas; Jarek Meller; Maria F Czyzyk-Krzeska
Journal:  Cancer Cell       Date:  2014-11-10       Impact factor: 31.743

Review 3.  Recovery of paraneoplastic hypercalcemia by sunitinib treatment for renal cell carcinoma: a case report and review of the literature.

Authors:  Halit Karaca; Ayhan Lale; Mustafa Dikilitas; Metin Ozkan; Ozlem Er
Journal:  Med Oncol       Date:  2009-10-15       Impact factor: 3.064

4.  Prognostic impact of paraneoplastic syndromes on patients with non-metastatic renal cell carcinoma undergoing surgery: Results from Canadian Kidney Cancer information system.

Authors:  Ryan Sun; Rodney H Breau; Ranjeeta Mallick; Simon Tanguay; Frederic Pouliot; Anil Kapoor; Luke T Lavallée; Antonio Finelli; Alan I So; Ricardo A Rendon; Adrian S Fairey; Jean-Baptiste Lattouf; Jun Kawakami; Bimal Bhindi; Naveen S Basappa; Lori A Wood; Georg A Bjarnason; Daniel Y C Heng; Rahul K Bansal
Journal:  Can Urol Assoc J       Date:  2021-04       Impact factor: 1.862

5.  Prognosis of metastatic renal cell carcinoma with first-line interferon-α therapy in the era of molecular-targeted therapy.

Authors:  Yoshiaki Kawano; Wataru Takahashi; Masatoshi Eto; Tomomi Kamba; Hideaki Miyake; Masato Fujisawa; Takao Kamai; Hirotsugu Uemura; Taiji Tsukamoto; Haruhito Azuma; Akio Matsubara; Kazuo Nishimura; Tsuyoshi Nakamura; Osamu Ogawa; Seiji Naito
Journal:  Cancer Sci       Date:  2016-06-14       Impact factor: 6.716

Review 6.  Animal Models of Cancer-Associated Hypercalcemia.

Authors:  Nicole A Kohart; Said M Elshafae; Justin T Breitbach; Thomas J Rosol
Journal:  Vet Sci       Date:  2017-04-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.